Literature DB >> 8824975

Persistent diarrhea in travelers.

H L DuPont1, E G Capsuto.   

Abstract

Most patients with traveler's diarrhea can be efficiently treated with available pharmacological agents. A more difficult problem is the persistent diarrhea (lasting > or = 14 days) that occurs in approximately 3% of travelers who have acute diarrhea. In the initial evaluation of these patients, ideally three stool samples should be obtained for examination for pathogens. If an agent is not identified or the patient has not responded to specific therapy, he or she may be empirically treated with an antimicrobial drug directed toward common bacterial enteropathogens, if such treatment has not already been administered. For those patients whose conditions do not respond, antiprotozoal therapy may be employed empirically. If diarrhea continues, then an endoscopic evaluation is indicated, and specific treatment can be given if an agent or condition is identified. A proportion of patients will continue to have diarrhea following empirical therapy and a gastroenterologic workup. These individuals are best given symptomatic treatment and reassured that the prognosis is good.

Entities:  

Mesh:

Year:  1996        PMID: 8824975     DOI: 10.1093/clinids/22.1.124

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Diarrhea in the International Traveler.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

Review 2.  [Fever after travel return].

Authors:  I Schedel
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

3.  Management of the returning traveler with diarrhea.

Authors:  Philippe P H de Saussure
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 4.  Prevention and self-treatment of traveler's diarrhea.

Authors:  David J Diemert
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

5.  Diarrhea in the returned traveler.

Authors:  J W Sanders; D R Tribble
Journal:  Curr Gastroenterol Rep       Date:  2001-08

6.  Travelers' diarrhea: modern concepts and new developments.

Authors:  Andrew W DuPont; Herbert L DuPont
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

Review 7.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

8.  Geography of intestinal permeability and absorption.

Authors:  I S Menzies; M J Zuckerman; W S Nukajam; S G Somasundaram; B Murphy; A P Jenkins; R S Crane; G G Gregory
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 9.  Use of rifaximin in gastrointestinal and liver diseases.

Authors:  Rani H Shayto; Rachel Abou Mrad; Ala I Sharara
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 10.  Travellers' diarrhoea: contemporary approaches to therapy and prevention.

Authors:  Herbert L DuPont
Journal:  Drugs       Date:  2006       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.